Companies
Ami Polymer
- Country
- India
Coverage
| CN | EU | US | |
|---|---|---|---|
| consumables | ✓ | ✓ | ✓ |
Regulatorsfdaema
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Revenue | ₹159.92 Cr for FY 2025 | thecompanycheck.com |
| Capacity | 25,000 tonnes per month | amipolymer.com |
| Certification | ISO 9001:2015, ISO 14001:2015, ISO 45001:2018, ISO 27001:2013, ISO 27001:2022, ISO 13485:2016, NSF-51, BPOG-standardized extractables, USP Class VI | pharmaceuticalbusinessreview.com · amipolymer.com |
| Regulatory approval | USFDA DMFs (#26201, 32560, 32558, 32559, 32561, 32549), FDA 21 CFR, EP 3.1.9, ADI Free, RoHS | pharmaceuticalbusinessreview.com · amipolymer.com |
| Production site | Silvassa (Masat and Kala facilities), India | pharmaceuticalbusinessreview.com · amipolymer.com |
| Headcount | 283 to 360 employees medium confidence | amipolymer.com · emis.com · thecompanycheck.com |
Independent sources: emis.com · pharmaceuticalbusinessreview.com · thecompanycheck.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Single-use assemblies | consumables | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.